Public signalCompany raiseAuto-indexed · Unverified
MindImmune Therapeutics, Inc. raised $10.2M
MindImmune Therapeutics, Inc.· KINGSTON, US· Pharmaceuticals· Filed Dec 5, 2025
MindImmune Therapeutics, Inc. reported raising capital. Based in KINGSTON, RHODE ISLAND, US. First sale reported 2025-11-24. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$10.2M
Confidence90%
On the record
- Location
- KINGSTON, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $10.2M
- Target amount
- $12.0M
- Filing date
- Dec 5, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 10,203,858 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Dec 5, 2025. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticals$10M – $100MCompany Raise
Are you associated with MindImmune Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record